JP2025513847A5 - - Google Patents

Info

Publication number
JP2025513847A5
JP2025513847A5 JP2024560379A JP2024560379A JP2025513847A5 JP 2025513847 A5 JP2025513847 A5 JP 2025513847A5 JP 2024560379 A JP2024560379 A JP 2024560379A JP 2024560379 A JP2024560379 A JP 2024560379A JP 2025513847 A5 JP2025513847 A5 JP 2025513847A5
Authority
JP
Japan
Prior art keywords
protein
nucleic acid
oligonucleotide
sugar
bond
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024560379A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025513847A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/018742 external-priority patent/WO2023201095A2/en
Publication of JP2025513847A publication Critical patent/JP2025513847A/ja
Publication of JP2025513847A5 publication Critical patent/JP2025513847A5/ja
Pending legal-status Critical Current

Links

JP2024560379A 2022-04-15 2023-04-14 オリゴヌクレオチド組成物及びそれに関連する方法 Pending JP2025513847A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US202263331756P 2022-04-15 2022-04-15
US63/331,756 2022-04-15
US202263397320P 2022-08-11 2022-08-11
US63/397,320 2022-08-11
US202263411062P 2022-09-28 2022-09-28
US63/411,062 2022-09-28
US202363454299P 2023-03-23 2023-03-23
US63/454,299 2023-03-23
PCT/US2023/018742 WO2023201095A2 (en) 2022-04-15 2023-04-14 Oligonucleotide compositions and methods relating thereto

Publications (2)

Publication Number Publication Date
JP2025513847A JP2025513847A (ja) 2025-04-30
JP2025513847A5 true JP2025513847A5 (cg-RX-API-DMAC7.html) 2026-04-22

Family

ID=88330318

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024560379A Pending JP2025513847A (ja) 2022-04-15 2023-04-14 オリゴヌクレオチド組成物及びそれに関連する方法

Country Status (10)

Country Link
US (1) US20250262235A1 (cg-RX-API-DMAC7.html)
EP (1) EP4507700A2 (cg-RX-API-DMAC7.html)
JP (1) JP2025513847A (cg-RX-API-DMAC7.html)
KR (1) KR20250004787A (cg-RX-API-DMAC7.html)
CN (1) CN119317632A (cg-RX-API-DMAC7.html)
AU (1) AU2023253657A1 (cg-RX-API-DMAC7.html)
CA (1) CA3247824A1 (cg-RX-API-DMAC7.html)
IL (1) IL316178A (cg-RX-API-DMAC7.html)
MX (1) MX2024012532A (cg-RX-API-DMAC7.html)
WO (1) WO2023201095A2 (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014010250A1 (en) 2012-07-13 2014-01-16 Chiralgen, Ltd. Asymmetric auxiliary group
EP3094728B1 (en) 2014-01-16 2022-03-09 Wave Life Sciences Ltd. Chiral design
CN117965536A (zh) 2015-07-22 2024-05-03 波涛生命科学有限公司 寡核苷酸组合物及其方法
MA46427A (fr) 2015-10-09 2018-08-15 Wave Life Sciences Ltd Compositions d'oligonucléotides et procédés associés
US11013757B2 (en) 2016-06-03 2021-05-25 Wave Life Sciences Ltd. Oligonucleotides, compositions and methods thereof
WO2018098264A1 (en) 2016-11-23 2018-05-31 Wave Life Sciences Ltd. Compositions and methods for phosphoramidite and oligonucleotide synthesis
WO2018237194A1 (en) 2017-06-21 2018-12-27 Wave Life Sciences Ltd. Compounds, compositions and methods for synthesis
CN111108096A (zh) 2017-09-18 2020-05-05 波涛生命科学有限公司 寡核苷酸制备技术
JP2021521140A (ja) 2018-04-12 2021-08-26 ウェイブ ライフ サイエンシズ リミテッドWave Life Sciences Ltd. オリゴヌクレオチド組成物及びその使用方法
CA3098624A1 (en) 2018-05-11 2019-11-14 Wave Life Sciences Ltd. Oligonucleotide compositions and methods of use thereof
AU2020241559A1 (en) 2019-03-20 2021-11-11 Wave Life Sciences Ltd. Technologies useful for oligonucleotide preparation
MX2021012981A (es) 2019-04-25 2022-01-18 Wave Life Sciences Ltd Composiciones de oligonucleotido y metodos de uso de las mismas.
EP4784753A2 (en) 2023-09-27 2026-08-05 Judo Bio Inc. Slc6a19-targeting modulatory nucleic acid agents
AU2024348221A1 (en) 2023-09-27 2026-04-30 Judo Bio Inc. Aminoglycosides for delivery of agents to the kidney
EP4784172A1 (en) 2023-09-27 2026-08-05 Judo Bio Inc. Polymyxins for delivery of agents to the kidney
CN117866028A (zh) * 2024-01-05 2024-04-12 苏州诺维康生物科技有限公司 一种医药中间体及其制备方法
WO2025213136A1 (en) * 2024-04-05 2025-10-09 Wave Life Sciences Ltd. Oligonucleotides comprising pn linkages and methods thereof
WO2026050243A1 (en) * 2024-08-26 2026-03-05 Korro Bio, Inc. Galnac conjugated oligonucleotides for rna editing
WO2026096688A1 (en) * 2024-10-30 2026-05-07 Wave Life Sciences Ltd. Oligonucleotide compositions and methods thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015886A (en) * 1993-05-24 2000-01-18 Chemgenes Corporation Oligonucleotide phosphate esters

Similar Documents

Publication Publication Date Title
JP7625555B2 (ja) 修飾されたガイドrna
KR102919364B1 (ko) 유전자 편집을 위한 변형된 가이드 rna
CN108350454B (zh) 等位基因选择性基因编辑及其用途
KR100875003B1 (ko) 누클레오시드의 위치 변형에 의한 올리고누클레오티드 CpG 매개성 면역 자극의 조절
JP2025516659A5 (cg-RX-API-DMAC7.html)
US7709617B2 (en) Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy
JP2023179428A (ja) メッセンジャーリボ核酸(mRNA)をコードする安定化された核酸
Wu et al. Nonenzymic template-directed synthesis on hairpin oligonucleotides. 2. Templates containing cytidine and guanosine residues
ES2585239T3 (es) Nuevos agonistas sintéticos de TLR9
JP2021522803A5 (cg-RX-API-DMAC7.html)
JPH07503613A (ja) ヌクレオザイム
US20020068709A1 (en) Therapeutic uses of LNA-modified oligonucleotides
Seela et al. Palindromic octa-and dodecanucleotides containing 2'-deoxytubercidin: synthesis, hairpin formation, and recognition by the endodeoxyribonuclease EcoRI
US7786089B2 (en) Immunostimulatory activity of immune modulatory oligonucleotides (IMO™) containing different lengths of palindromic segments
JP2023519274A5 (cg-RX-API-DMAC7.html)
PT851934E (pt) Plantas que sintetizam um amido modificado, processo para a sua produção e amido modificado
JP2018537528A (ja) Nlrp3遺伝子発現を阻害するための組成物およびその使用
JP2011135877A (ja) 炎症性症状を含む疾患を治療するための、オリゴヌクレオチド組成物および方法
JP4787409B2 (ja) 治療用ホスホジエステラーゼ阻害剤
JP2006528697A (ja) イムノマーを化学療法剤と組み合わせて用いる、癌の相乗的処置
CN110234326A (zh) 用于抑制因子xii基因表达的组合物和方法
JP2001512666A5 (cg-RX-API-DMAC7.html)
Townsend et al. Recognition of influenza A virus nucleoprotein by an H-2-restricted cytotoxic T-cell clone
CN119451666A (zh) 用于基因编辑系统的脂质纳米颗粒
JP3182243B2 (ja) 一本鎖dna−rnaハイブリッド分子の合成方法